Wiley Bros.-aintree Capital »

Travere Therapeutics shares owned by Wiley Bros.-aintree Capital

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Wiley Bros.-aintree Capital from 13F filings

Historical chart of Wiley Bros.-aintree Capital investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Wiley Bros.-aintree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Wiley Bros.-aintree Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $18k 16k 1.13